ACUS (Acusphere) YoY EBITDA Growth: 45.95% (As of Sep. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acusphere YoY EBITDA Growth?

Acusphere ACUS -90.00% YoY EBITDA Growth is 45.95% as of Sep. 2008.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Acusphere's YoY EBITDA Growth for the quarter that ended in Sep. 2008 was 45.95%.

Acusphere's EBITDA per Share for the three months ended in Sep. 2008 was $-1.57.

Acusphere YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Acusphere's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acusphere YoY EBITDA Growth Chart

Acusphere Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
YoY EBITDA Growth
Get a 7-Day Free Trial 80.58 56.58 -19.78 15.58 44.05

Acusphere Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.79 22.74 12.65 37.16 45.95

Acusphere YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Acusphere's YoY EBITDA Growth for the fiscal year that ended in Dec. 2007 is calculated as:

YoY EBITDA Growth (A: Dec. 2007 )
=(EBITDA per Share (A: Dec. 2007 )-EBITDA per Share (A: Dec. 2006 ))/ | EBITDA per Share (A: Dec. 2006 ) |
=(-10.539--18.836)/ | -18.836 |
=44.05 %

Acusphere's YoY EBITDA Growth for the quarter that ended in Sep. 2008 is calculated as:

YoY EBITDA Growth (Q: Sep. 2008 )
=(EBITDA per Share (Q: Sep. 2008 )-EBITDA per Share (Q: Sep. 2007 )) / | EBITDA per Share (Q: Sep. 2007 )) |
=(-1.574--2.912)/ | -2.912 |
=45.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 45.95% mean?
Acusphere (ACUS) has a YoY EBITDA Growth of 45.95% as of Sep. 2008. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Acusphere and its competitors.
Is Acusphere's YoY EBITDA Growth too high?
Acusphere's current YoY EBITDA Growth is 45.95%.
How does Acusphere's YoY EBITDA Growth compare to CNAB and PIRE?
Acusphere's YoY EBITDA Growth of 45.95% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Acusphere and its competitors. Acusphere's current YoY EBITDA Growth is 45.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusphere stock overvalued right now?
Acusphere (ACUS) has a current YoY EBITDA Growth of 45.95%. The current YoY EBITDA Growth is 45.95%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Acusphere (ACUS), the current YoY EBITDA Growth is 45.95% as of Sep. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acusphere Business Description

Address 99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.